High-value care: overuse, underuse and misuse
- Concept
More care is not better care. Tests and treatments that do not help still cost money and can harm, while needed care is often missed.
What it is
High-value care gives patients the benefits they need at a cost and risk worth paying, and avoids care that adds harm or cost without benefit. Quality problems fall into three groups: overuse (care whose harms or costs outweigh its benefits), underuse (failure to give care that would help) and misuse (appropriate care given in a way that causes avoidable harm). Campaigns such as Choosing Wisely, opioid stewardship and honest conversations about cost are ways to move towards value.
Key facts
- Choosing Wisely worked through conversations: clinician and patient discussing whether a test or treatment is truly needed.
- CDC 2022 guideline covers adults 18 and older with acute, subacute or chronic pain in outpatient care; it excludes sickle cell disease, cancer-related pain, palliative and end-of-life care, and opioid use disorder treatment.
- Its 4 areas: whether to start opioids; choosing the opioid and dose; duration and follow-up; assessing risk and addressing harms.
- Stewardship principles: try non-opioid options when they work as well, set goals with the patient, prescribe no more than needed, review regularly and avoid abrupt stopping.
- Value-based payment links payment to quality measures rather than volume of services.
Worked example
- A made-up clinic sees 200 adults a year with low back pain and no red flags; 60 (30 %) get lumbar imaging within 6 weeks.
- Imaging in this group rarely changes management, and incidental findings lead to extra referrals.
- The clinic adopts a recommendation to avoid early imaging without red flags, a decision-support prompt and a patient handout.
- One year later, 20 of 200 (10 %) are imaged: 60 − 20 = 40 studies avoided, a two-thirds fall.
- Referrals after incidental findings fall from 12 to 4.
- Balancing measures: no serious diagnosis was missed in chart review, and return visits stayed at 18 %.
- Reading: less care here was better care: fewer cascades and the same outcomes.
Overuse, underuse and misuse
| Type | Definition | Example | Typical fix |
|---|---|---|---|
| Overuse | Care given when its harm or cost exceeds the benefit | MRI for low back pain without red flags | Recommendations, decision support, conversation |
| Underuse | Beneficial care not given | Eligible adult not offered colorectal screening | Reminders, registries, outreach |
| Misuse | Right care given wrongly, with avoidable harm | Correct antibiotic given despite a recorded allergy | Safety systems: alerts, forcing functions |
Markers
- Overuse
- Underuse
- Misuse
- Choosing Wisely
- Low-value care
In practice
- Before ordering, ask: will the result change what I do? If not, discuss not doing it.
- Ask every patient whether cost is a barrier to the plan; offer generic or equally effective options.
- For pain, agree functional goals, review benefit and harm at each visit and avoid sudden opioid stopping in a patient on long-term treatment.
Common traps
- More testing is defensive and therefore safer: low-value tests cause false positives, cascades and harm, as well as cost
- Choosing Wisely is a rationing tool: it targeted care with no benefit, through conversations, not denial of needed care
- The CDC 2022 guideline requires tapering every patient on long-term opioids: it warns against rapid tapering and abrupt stopping and is not an inflexible standard
- Misuse means overuse: misuse is appropriate care delivered with an avoidable error, such as giving a drug the patient is allergic to
Test yourself
Think of the answer, then tap the question to see it.
A patient with uncomplicated viral bronchitis receives antibiotics and develops a rash. Is this overuse, underuse or misuse?
Overuse: antibiotics were not indicated, so any harm comes from care that should not have been given.
Why can a low-value test harm a patient even when the test itself is safe?
Incidental findings and false positives start a cascade of more tests, procedures, anxiety and cost, each with its own risk.
A patient on long-term opioids for years asks whether the new guideline means they must stop now. What does the CDC 2022 guideline say?
It is not an inflexible standard and warns against rapid tapering or abrupt stopping; changes are made with the patient, weighing benefits and risks.
A patient says the prescribed inhaler is too expensive and has stopped using it. What is the high-value response?
Discuss cost openly and offer an equally effective, cheaper option or support programme; an unaffordable treatment has no value if it is not taken.
Connections
Educational content on epidemiological and statistical methods; the examples use made-up numbers to teach the calculation. Not a clinical or legal guide: current Colombian rules are in the official sources.
Sources: Choosing Wisely | ABIM Foundation (ABIM Foundation, 2026); 2022 CDC Clinical Practice Guideline at a Glance | Overdose Prevention | CDC (Centers for Disease Control and Prevention, 2024); CMS' Value-Based Programs | CMS (Centers for Medicare & Medicaid Services, 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
